Kindeva Drug Delivery

Kindeva Drug Delivery is an industry-leading global CDMO specializing in the development and manufacturing of drug-device combination products. With roots dating back to the invention of the pressurized metered-dose inhaler in the mid-twentieth century as part of 3M’s healthcare business, it now provides end-to-end services across inhalation therapies, transdermal patches, injectables/autoinjectors—including commercial supply of FDA-approved products such as DuoDote® nerve agent antidote kits and fentanyl transdermal systems. The company has expanded its capabilities through its merger with Meridian Medical Technologies in late 2022. It supports both clinical-stage and commercial-stage projects for major pharmaceutical partners worldwide[5][10].